The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Microbiology
(Oct 2022)
Rethinking treatment paradigms for the deployment of SARS-CoV-2 antiviral drugs on the shifting landscape of new variants
Maxime Hentzien,
Andrew Owen,
Nathalie Strub-Wourgaft,
Carmen Pérez-Casas,
Marius Trøseid,
Alexandra Calmy
Affiliations
Maxime Hentzien
HIV/AIDS Unit, Infectious Diseases Division, Geneva University Hospitals, Geneva, Switzerland
Andrew Owen
Centre of Excellence in Long-acting Therapeutics (CELT), University of Liverpool, Liverpool, United Kingdom
Nathalie Strub-Wourgaft
COVID Response and Pandemic Preparedness Director, Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland
Carmen Pérez-Casas
Strategy, Unitaid, Geneva, Switzerland
Marius Trøseid
Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Oslo, Norway
Alexandra Calmy
HIV/AIDS Unit, Infectious Diseases Division, Geneva University Hospitals, Geneva, Switzerland
DOI
https://doi.org/10.3389/fmicb.2022.998287
Journal volume & issue
Vol. 13
Abstract
Read online
No abstracts available.
Keywords
COVID-19
direct-acting antivirals
immunocompromised
resistance
variant emergence
monoclonal antibodies
WeChat QR code
Close